CLASS II Device recall · Reported 4 Jul 2012 · FDA Enforcement Report

PTS Panels Creatinine test strips recalled by Polymer Technology Systems

Polymer Technology Systems is recalling PTS Panels Creatinine test strips, distributed nationwide in the US. The recall was initiated on 15 May 2012 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesCat No. 1720; and Lot number F103
Quantity recalled1650 vials

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1903-2012
FDA event ID
61966
Recalling firm
Polymer Technology Systems, Indianapolis, IN
Classification
Class II
Status
Terminated
Recall initiated
15 May 2012
FDA classified
28 Jun 2012
Reported
4 Jul 2012
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

15 May 2012Recall initiated by company
28 Jun 2012Classified by FDA+44 days
4 Jul 2012Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

During a routine product investigation, a creatinine sample with a value less than 1.0 mg/dl was tested on a version 2.60 CardioCek PA meter and the meter provided a result of 0.08mg/dl, which is not the reportable measuring range for the CardioChek PA meter for the creatinine assay.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

PTS Panels Creatinine test strips. PTS Panels Creatinine Test Strips are intended to measure creatinine in whole blood. Creatinine measurements are used in the diagnosis and treatment of renal (kidney) diseases and in the monitoring of renal dialysis. This system is intended for the professional use for accurately and reproducibly measuring creatinine in human whole blood obtained from a finger stick sample

Where it was distributed

Worldwide Distribution -- Nationwide Distribution including the states of CA and VA., and the countries of China, Poland, Ireland and France.

Nationwide CaliforniaVirginia

Questions about this recall

Why was it recalled?

During a routine product investigation, a creatinine sample with a value less than 1.0 mg/dl was tested on a version 2.60 CardioCek PA meter and the meter provided a result of 0.08mg/dl, which is not the reportable measuring range for the CardioChek PA meter for the creatinine assay.

Which lots are affected?

Cat No. 1720; and Lot number F103

Where was it sold?

Worldwide Distribution -- Nationwide Distribution including the states of CA and VA., and the countries of China, Poland, Ireland and France.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Polymer Technology Systems

All 21

Other Insulin Pumps & Glucose Monitors recalls

All 467